Clinical Trial

Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms

Name: Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms — clinical trial record (NCT07337967)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Reticulocyte parameters as early indicators of bone marrow erythropoietic activity in chronic B lymphoproliferative neoplasms

Trial Details

NCT Number	NCT07337967
Lead Sponsor	Huda Ahmed Abdelsabour Abdelwahab
Conditions	B Chronic Lymphocytic Leukemia
Enrollment	120 participants
Start Date	2026-01-01
Primary Completion	2027-02-01 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-13